Dermata Therapeutics, Inc (DRMA) Misses Q2 EPS by 166c
Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q2 EPS of ($1.66).
For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.
Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q2 EPS of ($1.66).
For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.